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Figure 1. Schematic Diagram Showing Relationship of RKIP to Its
Targets and Locostatin
Active RKIP inhibits Raf-1 kinase (Raf1). When RKIP is phosphory-
lated by protein kinase C (PKC), it no longer inhibits Raf-1 but in-
stead inhibits Grk2. The question mark indicates that whether or
not locostatin inhibits phosphorylated RKIP is currently unknown.
ticular gene and gene product linked to a phenotype by
mapping (or a related approach) and by rescue. Here,
rather than first narrowing the field to “likely suspects”
and potentially missing unexpected targets, Zhu et al.
[1] took advantage of the fact that locostatin covalently
modifies its targets, and then subjected the entire pro-
teome to labeling with tritiated locostation. Only four
proteins were thus identified, and of these, only RKIP
subsequently satisfied further tests (see above).
Fourth, some of the most useful genetic screens are
for conditional (e.g., temperature-sensitive) mutants,
which permit disruption of a particular protein at the
investigator’s convenience. But conditional mutants can
be hard to come by. Chemical genetics, however, pro-
vides the pharmacological equivalent of a conditional
mutant, in that a drug can be applied at any time. This
is a particular advantage for proteins likely to play mul-
tiple roles during the lifetime of a cell, tissue, or organ-
ism. RKIP, for example, has previously been implicated
not only in cell division, but also in differentiation and
programmed cell death [4, 16]. Thus, simply disrupting
RKIP function by gene knockout in a developing organ-
ism might fail to reveal its role in cell locomotion. Since
most proteins play multiple roles, such pharmacologi-
cal conditionality is a great advantage.
Just how far can functional analogies between chem-
ical genetics and classic genetics be pushed? After the
success of these studies, one can’t help but wonder if
other genetic strategies will work for chemical genetics.
For example, it might be possible to identify other play-
ers that work in the RKIP pathway by screening for
dependent inhibition of cell movement. Not only might
such approaches reveal exactly how RKIP regulates cell
motility, the former also has the potential to identify novel
therapeutic agents, as RKIP levels are sharply reduced in
a number of tumors, and it has recently been suggested
that small molecules that modulate RKIP targets offer a
promising approach for cancer treatment [4, 16].
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from the Cell Surface
Understanding the dynamic roles that proteins play
in cell biology requires tools to selectively label these
biomolecules in living systems. Yin and colleagues
[1] showcase the power of a novel chemical labeling
t
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technology for tracking receptor-ligand interactions
n native cellular environments.
istorically, the tagging of proteins for optical analysis
n cells and organisms has been accomplished through
enetically encoded fusion to fluorescent proteins (e.g.,
reen fluorescent protein [GFP]) [2]. GFP fusion pro-
eins have profoundly impacted cell biological research,
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955where these reagents are now routinely employed to
monitor dynamics in protein localization, trafficking,
stability and interactions. Despite their versatility and
power, GFP fusion proteins do exhibit some shortcom-
ings. First, GFP and related fluorescent proteins are
large (>200 amino acids) and therefore may disrupt the
function of their fusion partners. Second, only a limited
number of fluorescent protein variants are available for
routine applications, thus restricting the multidimen-
sionality of molecular imaging experiments. Finally,
these probes provide exclusively an optical readout of
protein behavior; additional tags, such as photocross-
linkers or biotin, are desired that can be used to profile
a wider range of protein functions (e.g., protein-protein
interactions, activity, and state of modification). To
address these challenges, chemical biologists have in-
troduced several exciting strategies for site-specific
chemical modification of proteins in native environ-
ments [3–5]. In this issue of Chemistry and Biology, Yin
and colleagues showcase the power of one of these
chemical labeling strategies for visualizing interactions
between the transferrin receptor 1 (TfR1) and its natural
ligand transferrin in living cells [1].
To accomplish the site-specific labeling of TfR1 in liv-
ing cells, the authors first fused an 80 residue peptide
carrier protein (PCP) excised from a nonribosomal pep-
tide synthetase to the extracellular C terminus of the
receptor. Cell surface-expressed TfR1-PCP was then
chemically modified by the enzyme phosphopantethei-
nyl transferase Sfp, which attaches a phosphopante-
theine group derived from coenzyme A (CoA) to a spe-
cific serine residue on PCP via a phosphodiester bond
[6]. Importantly, Sfp has been found to accept a wide
range of CoA derivatives conjugated to different molec-
ular probes, including biotin and several fluorophores
[7, 8]. Incubation of TfR1-PCP-transfected cells with
Sfp and biotin-CoA resulted in rapid (< 20 min) and ro-
bust biotinylation of TfR1-PCP as judged by streptavi-
din blotting. Endogenous streptavidin binding proteins
were also observed in this experiment, suggesting that
a two-step labeling profile, where fluorescent streptavi-
din is used to image biotinylated TfR1-PCP, may pro-
duce high background signals. Accordingly, the authors
elected to label TfR1-PCP directly with a fluorophore by
treatment of transfected cells with Sfp and an Alexa
Fluor 488-CoA conjugate.
To monitor TfR1-transferrin interactions over time in
living cells, the authors conducted fluorescence reso-
nance energy transfer (FRET) studies with Alexa Fluor
488-labeled TfR1-PCP (donor) and Alexa Fluor 568-
labeled transferrin (TF-Alexa 568; acceptor). Cell sur-
face FRET signals were observed almost immediately
(<1 min) upon addition of TF-Alexa 568. Interestingly,
within 15 min, large intracellular aggregates of FRET
signals were detected, likely representing TfR1-transfer-
rin complexes accumulating in recycling endosomes.
Thus, these studies have provided the first direct visual
confirmation that the TfR1-transferrin interaction is
maintained during the endocytosis/exocytosis cycle.
Overall, these studies offer a tantalizing glimpse of
the potential impact that chemistry can have on the
study of cell biological systems. The labeling of cell sur-
face proteins on specific extracellular sites with fluoro-
phores (or other reporter tags) has historically provento be a challenging technical endeavor. The Sfp-PCP
system, along with related approaches like the phos-
phopantetheinyl transferase-ACP [9] and biotin ligase-
keto-biotin [10] technologies, promise to reduce such
experiments to a routine practice, providing research-
ers with an unprecedented level of spatial and temporal
control to probe the function of proteins in living sys-
tems. Although the requirement of exogenously added
enzymes (phosphopantetheinyl transferases and biotin
ligase) currently limits these strategies to the analysis
of extracellular/plasma membrane proteins, other com-
plementary chemical labeling systems have been de-
scribed that function inside cells. For example, Johns-
son and colleagues have shown that cytosolic proteins
fused to the O6-alkylguanine transferase (hAGT) en-
zyme can be covalently modified with a variety of
reporter tagged-O6-benzylguanine suicide substrates
[11]. Additionally, noncovalent ligand-receptor pairs,
such as trimethoprim-dihydrofolate reductase, can be
also used for chemical tagging of intracellular fusion
proteins [12]. For a more detailed discussion of various
strategies for site-specific chemical labeling of proteins
in living cells, the reader is referred to one of several
excellent reviews that have recently appeared in the lit-
erature [3–5].
When contemplating the future direction of this excit-
ing field, one provocative challenge immediately be-
comes apparent—the extension of site-specific chemi-
cal labeling from the culture dish to living animals.
While many biological processes can be characterized
in cell culture, there are also surely a plethora of re-
markable changes in protein localization, transport, and
complexation that occur selectively in the intricate
three-dimensional environment of intact tissues. Ad-
vanced imaging methods like two-photon microscopy
[13] offer a wonderful opportunity to explore such dy-
namic molecular events in vivo. However, site-specific
chemical labeling methods will first need to overcome
some technical hurdles before they can be used to re-
port on the functional state of proteins in vivo, including
the stable endogenous production of fusion proteins,
as well as the efficient delivery of modification enzymes
and reporter-tagged substrates. The former issue should
be addressable using targeted transgenic technologies
like gene “knockins,” where the gene encoding a pro-
tein of interest is replaced by homologous recombina-
tion with a gene encoding a “chemically taggable” vari-
ant of this protein. This approach would also have the
desirable effect of placing the fusion protein under con-
trol of the endogenous promoter of the parent gene,
thus resulting in native levels of fusion protein expres-
sion and avoiding potential biological artifacts that can
accompany protein overexpression. The in vivo produc-
tion of labeling enzymes like Sfp and biotin ligase could
also conceivably be accomplished by transgenic meth-
ods—in this case, simple overexpression would pre-
sumably suffice (and perhaps be preferred). Success
with delivering (and eventually washing out) reporter-
tagged labeling reagents will likely depend on systemic
or local pharmacological administration, and thus be
subject to the notoriously unpredictable whims of com-
pound distribution, metabolism, and excretion kinetics.
Nonetheless, this author is optimistic that, through rig-
orous experimental inquiry, an empirical solution will be
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sion of site-specific chemical labeling in vivo. Can you
then imag(e)ine the possibilities?
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